Latest Investment News

Rio Tinto reported robust third quarter 2025 production results, highlighted by record outputs in bauxite and copper, and an upgraded bauxite production forecast. Key projects like Simandou and Oyu Tolgoi continue to progress on schedule, underpinning the company’s growth trajectory.

Garda Property Group has announced its distribution components for the year ending June 2026, highlighting key tax elements and a total cash payout scheduled for mid-October.

The Supreme Court of New South Wales has approved the scheme for Pacific Equity Partners to acquire Johns Lyng Group, setting the stage for a significant ownership change and trading suspension on the ASX.

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.

Cedar Woods Properties has updated its dividend announcement for the six months ending June 2025, confirming a fully franked 19 cents per share payout and revealing key details on its Dividend Reinvestment and Bonus Security Plans.

AustChina Holdings has received a non-binding proposal from Bluestone Energy to invest $1.5 million via a large share placement, potentially fueling new acquisitions and exploration efforts.

Clime Investment Management has completed a $2.3 million placement and announced a bonus option issue, positioning itself for growth as the Australian wealth management sector consolidates.

Equity Trustees faces an expanded Federal Court claim from ASIC seeking compensation for superannuation members after a $73 million revaluation hit the Shield Master Fund. The trustee disputes liability and supports liquidation efforts to recover member funds.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.

Eclipse Metals has raised $4 million to accelerate drilling and resource upgrades at its Greenland rare earths project, while preparing for a potential NASDAQ dual listing.